Clinical Trials on Neutral Lipid Storage Disease With Myopathy
Total 1894 results
-
University of MinnesotaRecruitingGaucher DiseaseUnited States
-
TakedaNot yet recruiting
-
Duke UniversityRecruiting
-
TakedaCompletedGaucher DiseaseUnited States
-
ShireCompletedGaucher DiseaseIndia
-
PfizerCompleted
-
ShireQuintiles, Inc.Completed
-
ISU Abxis Co., Ltd.CompletedGaucher DiseaseAustralia
-
ProtalixCompleted
-
ISU Abxis Co., Ltd.Withdrawn
-
Genzyme, a Sanofi CompanyCompleted
-
ProtalixCompleted
-
University Hospital, Clermont-FerrandUnknown
-
Brigham and Women's HospitalGenzyme, a Sanofi CompanyUnknown
-
ProtalixCompleted
-
ShireTerminated
-
TakedaCompleted
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseCanada, Russian Federation, Tunisia
-
ShireCompleted
-
PfizerCompletedGaucher DiseaseUnited Kingdom, Canada, Israel, United States, Australia, Spain
-
PfizerCompletedGaucher DiseaseChile, United Kingdom, Canada, Spain, Israel, United States, Australia, South Africa
-
PfizerCompletedGaucher DiseaseIsrael, Paraguay, South Africa
-
Yasmeen Abd Elbaset HamzaaUnknownGaucher Disease
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States, Sweden, India, Netherlands, Austria, Japan, China, Serbia, France, Croatia, Australia, Portugal, Canada, Brazil, Greece, Romania, Russian Federation
-
ISU Abxis Co., Ltd.Completed
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | Cholesterol Ester Storage Disease(CESD) | LAL-DeficiencyFrance, United States, United Kingdom, Czechia
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | LAL-Deficiency | Cholesterol Ester Storage Disease (CESD)France, United Kingdom, United States, Canada, Czechia
-
National Institute of Neurological Disorders and...Completed
-
University of MinnesotaRecruitingGaucher Disease, Type 3United States
-
TakedaActive, not recruiting
-
Shaare Zedek Medical CenterShireCompletedGaucher Disease, Type 1
-
Shaare Zedek Medical CenterPfizerCompletedGaucher Disease, Type 1
-
National Taiwan University HospitalSanofiCompleted
-
ShireCompletedGaucher Disease, Type 1Israel, Paraguay, Argentina, Russian Federation, Tunisia
-
ShireCompletedGaucher Disease, Type 1Spain, Israel, United States, India, Paraguay, United Kingdom, Russian Federation, Tunisia, Argentina
-
PfizerWithdrawnType 1 Gaucher DiseaseUnited States
-
National Taiwan University HospitalActelionUnknown
-
ActelionCompletedGaucher Disease Type 1United States, Taiwan, Canada, Spain, Australia, France, Brazil, Hungary, Czechia, Germany, Italy, Netherlands, United Kingdom
-
National Institute of Neurological Disorders and...CompletedType 2 Gaucher DiseaseUnited States
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States
-
Hospital Universitario Reina Sofia de CordobaSpanish Society of Family and Community MedicineCompletedPatients With DyslipidemiaSpain
-
AstraZenecaCompletedPatients With DyslipidemiaBrazil
-
SanofiCompletedGaucher's DiseaseUnited States
-
ShireCompletedGaucher DiseaseUnited States, Spain, United Kingdom, Israel
-
ShireCompletedGaucher DiseaseIsrael, Romania, Serbia